Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,482.00    -20.00 (-1.33%)
Bid:
1,468.00
Ask:
1,478.00
Spread: 10.00 (0.681%)
Market Cap: £772.28m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Acquisition

6 Mar 2023 07:00

RNS Number : 8974R
M. P. Evans Group PLC
06 March 2023
 

M.P. EVANS GROUP PLC

("The Group" or "M.P.Evans")

 

ACQUISITION OF PLANTED LAND IN INDONESIA

 

The board of M.P.Evans, the producer of sustainable palm oil, is pleased to announce, in line with its growth strategy, the acquisition, for cash, of additional planted land, adjacent to the Group's Simpang Kiri estate, in Indonesia.

 

The Group has been successful in acquiring 100% of the shares in two Indonesian companies, PT Teunggulon Raya and PT Dharma Agung, which between them own 2,100 hectares planted with oil palm. All the land being acquired is fully titled, with long leaseholds already established with the Indonesian government, in a similar way to the Group's existing properties. The planted land is close to the Group's Simpang Kiri estate in Aceh Province, Northern Sumatra. Total costs associated with the acquisition, including the assumption of liabilities within the companies acquired, are estimated to be US$14.3 million, giving rise to a purchase cost of US$6,800 per hectare. The Group does expect to replant some of the acquired areas in the near term, as part of its plans to bring them up to Group standards.

 

Following the acquisition, the Group will have an expanded planted area of 4,800 hectares at or around the Simpang Kiri estate, and the potential to build its own palm-oil mill there. If one is developed, the Group would reach a position of processing 100% of its own crop, as well as further increasing its sustainable palm-oil production.

 

Commenting on the acquisition, Peter Hadsley-Chaplin, executive chairman, said:

 

"This is an excellent acquisition, fully in keeping with our stated strategy and supported by the strength of the Group's balance sheet. Thanks to a combination of the good price at which it has been secured, and the added scale it gives the Group around Simpang Kiri, these additional hectares are further fuel for the M.P.Evans growth engine."

 

6 March 2023

 

Enquiries:

M.P. Evans Group PLC

+44 (0)1892 516333

Peter Hadsley-Chaplin

Executive chairman

Matthew Coulson

Chief executive

Luke Shaw

Chief financial officer

Peel Hunt LLP (Nomad and joint broker)

+44 (0)20 7418 8900

Dan Webster, Andrew Clark, Lalit Bose

finnCap (Joint broker)

+44 (0)20 7220 0500

Tim Redfern, Harriet Ward

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack, Francis Kerrigan, Amelia Craddock

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUPUAUWUPWGAW
Date   Source Headline
1st Aug 202212:26 pmRNSTotal Voting Rights
29th Jul 20227:00 amRNSTransaction in Own Shares
27th Jul 20227:00 amRNSDirectorate Change
26th Jul 20227:00 amRNSTransaction in Own Shares
21st Jul 20227:00 amRNSCrop and production update
19th Jul 20227:00 amRNSIndonesian Export Tax Update
14th Jul 20227:00 amRNSTransaction in Own Shares
13th Jul 20223:03 pmRNSDirector/PDMR Shareholding
13th Jul 20227:00 amRNSTransaction in Own Shares
8th Jul 20224:06 pmRNSDirector/PDMR Shareholding
5th Jul 202211:46 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSTransaction in Own Shares
1st Jul 20227:00 amRNSAIM Rule 17
1st Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
28th Jun 20227:00 amRNSTransaction in Own Shares
27th Jun 20227:00 amRNSTransaction in Own Shares
24th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 20227:00 amRNSTransaction in Own Shares
21st Jun 20227:00 amRNSTransaction in Own Shares
21st Jun 20227:00 amRNSIndonesian Export Tax Update
20th Jun 20227:00 amRNSTransaction in Own Shares
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSShare buyback programme
10th Jun 20221:22 pmRNSResult of AGM
10th Jun 20227:00 amRNSTrading Statement
1st Jun 20227:00 amRNSAGM update
31st May 20223:09 pmRNSCorrection AGM date
24th May 20227:00 amRNSDirectorate Change
23rd May 20229:35 amRNSLifting of Indonesian palm oil export ban
29th Apr 20227:00 amRNSIndonesian palm oil export ban update
26th Apr 20227:00 amRNSAppointment of Chief financial officer
25th Apr 20227:00 amRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSAIM Rule 20 Notice
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSFinal Results
18th Mar 20224:04 pmRNSCPO Export levy update
1st Mar 20227:00 amRNSNotice of Results and Investor Presentation
28th Jan 20229:45 amRNSDirectorate Change
20th Jan 20225:18 pmRNSDirector/PDMR Shareholding
17th Jan 20227:00 amRNSCrop, production and special dividend
4th Jan 20223:18 pmRNSBlock listing Interim Review
15th Dec 202110:26 amRNSDirector/PDMR Shareholding
5th Nov 20217:00 amRNSAppointment of chief executive
15th Oct 20217:00 amRNSCompletion of land disposal
17th Sep 20217:00 amRNSAIM rule 20
17th Sep 20217:00 amRNSTotal Voting Rights
13th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSNotice of Results and Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.